{"id":23815,"date":"2012-08-10T12:51:17","date_gmt":"2012-08-10T17:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23815"},"modified":"2018-04-14T02:07:36","modified_gmt":"2018-04-14T07:07:36","slug":"23815","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/23815\/","title":{"rendered":"2012 \u5e74 8 \u6708 10 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN_8-10-12.pdf\">\u6253\u5370\u7248\u672c<\/a><\/p>\n<p>***********************************<br \/>\n<strong>Brakke \u54a8\u8be2\u516c\u53f8\u7684 <br \/>\n2012 \u5e74 8 \u6708 10 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca<br \/>\n<\/strong>\u7248\u6743\u6240\u6709 \u00a9 Brakke \u54a8\u8be2\u516c\u53f8<br \/>\n&nbsp;<br \/>\n\u7f16\u8f91\uff1aLynn Fondon DVM MBA<br \/>\n************************************<br \/>\n\u65b0\u95fb\u62a5\u9053\uff1a<br \/>\n&nbsp;<br \/>\n<u>Brakke \u65b0\u95fb<br \/>\n<\/u>\u5b9e\u8df5\u7ba1\u7406<br \/>\n&nbsp;<br \/>\n<u>\u76c8\u5229\u65b0\u95fb<br \/>\n<\/u>\u8d6b\u65af\u5361<br \/>\n\u96c0\u5de2<br \/>\n\u5149\u8c31\u54c1\u724c<br \/>\n&nbsp;<br \/>\n<u>\u5176\u4ed6\u65b0\u95fb<br \/>\n<\/u>\u78a7\u73ca<br \/>\n\u751f\u5316\u4eba<br \/>\nCeva\u2014\u2014\u603b\u90e8<br \/>\nCeva \u2013 \u75ab\u82d7<br \/>\n\u5e1d\u65af\u66fc<br \/>\n\u5c5e<br \/>\n\u7231\u5fb7\u58eb<br \/>\n\u6d1b\u66fc<br \/>\n\u660e\u6cbb\u5236\u836f<br \/>\n\u9ed8\u514b<br \/>\n\u5fae\u6ce2\u8f90\u5c04\u8ba1<br \/>\n\u7ebd\u91d1<br \/>\nNexcyon \u5236\u836f\u516c\u53f8<br \/>\nNexvet \u751f\u7269\u5236\u836f<br \/>\n\u8bfa\u534e<br \/>\n\u98de\u9a6c\u5b9e\u9a8c\u5ba4<br \/>\n\u5149\u8c31\u96c6\u56e2<br \/>\n\u6258\u5c14\u56fe\u52a0<br \/>\n\u7ef4\u514b<br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n<strong>2012\u52a8\u7269\u4fdd\u5065\u6295\u8d44\u8bba\u575b<br \/>\n2012 \u5e74 8 \u6708 28 \u65e5\u661f\u671f\u4e8c<br \/>\n\u582a\u8428\u65af\u57ce<br \/>\n&nbsp;<br \/>\n<\/strong>\u4eca\u5e74\u7684\u582a\u8428\u65af\u57ce\u52a8\u7269\u4fdd\u5065\u6295\u8d44\u8bba\u575b\u5c06\u6709\u6765\u81ea\u4e16\u754c\u5404\u5730\u7684 13 \u5bb6\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u53d1\u8868\u6f14\u8bb2\u3002\u6f14\u8bb2\u5185\u5bb9\u5305\u62ec\u8bca\u65ad\u3001\u8f93\u9001\u7cfb\u7edf\u3001\u751f\u7269\u5236\u5242\u3001\u836f\u54c1\u3001\u8bbe\u5907\u3001\u751f\u957f\u4fc3\u8fdb\u5242\u3001\u9176\u548c\u80bf\u7624\u5b66\u7b49\u3002<br \/>\n&nbsp;<br \/>\n\u5982\u9700\u6ce8\u518c\uff0c\u8bf7\u8bbf\u95ee <a href=\"http:\/\/www.kcanimalhealthforum.com\/index.php\/register-to-attend\/\">http:\/\/www.kcanimalhealthforum.com\/index.php\/register-to-attend\/<\/a> <br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.kcanimalhealthforum.com\">www.kcanimalhealthforum.com<\/a><br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n\u516c\u53f8\u4e1a\u7ee9\u53d1\u5e03<br \/>\n&nbsp;<br \/>\n&gt; Heska \u516c\u5e03\u4e86\u622a\u81f3 2012 \u5e74 6 \u6708 30 \u65e5\u7684\u7b2c\u4e8c\u5b63\u5ea6\u8d22\u52a1\u4e1a\u7ee9\u3002\u7efc\u5408\u6536\u5165\u4e3a $1830 \u4e07\u7f8e\u5143\uff0c\u4e0e 2011 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u76f8\u6bd4\u589e\u957f\u4e86 5%\u3002\u51c0\u6536\u5165\u4e3a $262,000 \u7f8e\u5143\uff0c\u800c 2011 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u7684\u51c0\u6536\u5165\u4e3a $457,000 \u7f8e\u5143\u3002\u6838\u5fc3\u4f34\u4fa3\u52a8\u7269\u4fdd\u5065\u6536\u5165\u4e3a $1570 \u4e07\u7f8e\u5143\uff0c\u4e0e 2011 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u76f8\u6bd4\u589e\u957f\u4e86 12%\u3002\uff08MSN Money\uff09 <br \/>\n&nbsp;<br \/>\n&gt; \u96c0\u5de2\u516c\u53f8\u516c\u5e03\u4e86 2012 \u5e74\u4e0a\u534a\u5e74\u4e1a\u7ee9\u3002\u5ba0\u7269\u62a4\u7406\u4e1a\u52a1\u6536\u5165\u589e\u957f 8% \u81f3 52 \u4ebf\u745e\u58eb\u6cd5\u90ce\uff08$53 \u4ebf\uff09\u3002 <br \/>\n&nbsp;<br \/>\n&gt; Spectrum Brands Holdings \u516c\u5e03\u4e86 2012 \u8d22\u5e74\u7b2c\u4e09\u5b63\u5ea6\u7684\u8d22\u52a1\u4e1a\u7ee9\u3002\u5168\u7403\u5ba0\u7269\u7528\u54c1\u90e8\u95e8\u62a5\u544a\u79f0\uff0c2012 \u8d22\u5e74\u7b2c\u4e09\u5b63\u5ea6\u7684\u51c0\u9500\u552e\u989d\u4e3a $1.58 \u4ebf\u7f8e\u5143\uff0c\u6bd4\u53bb\u5e74\u540c\u671f\u589e\u957f 10%\uff0c\u4e3b\u8981\u5f97\u76ca\u4e8e\u6536\u8d2d FURminator \u5e26\u6765\u7684 $1040 \u4e07\u7f8e\u5143\u6536\u5165\u3002\uff08Business Wire\uff09 <br \/>\n&nbsp;<br \/>\n************************************<br \/>\n<strong>AVMA \u5e74\u5ea6\u5927\u4f1a<br \/>\n\u52a0\u5229\u798f\u5c3c\u4e9a\u5dde\u5723\u5730\u4e9a\u54e5<br \/>\n2012 \u5e74 8 \u6708 3 \u65e5\u81f3 7 \u65e5<br \/>\n<\/strong>&nbsp;<br \/>\n\u5728\u5723\u5730\u4e9a\u54e5\u4e3e\u884c\u7684\u7f8e\u56fd\u517d\u533b\u534f\u4f1a\u5e74\u5ea6\u5927\u4f1a\u5438\u5f15\u4e86\u8d85\u8fc7 8,600 \u540d\u53c2\u4f1a\u8005\uff0c\u5176\u4e2d\u5305\u62ec 3,800 \u540d\u517d\u533b\u548c\u517d\u533b\u6280\u5e08\u3002\u9664\u4e86\u63d0\u4f9b\u8d85\u8fc7 1,000 \u5c0f\u65f6\u7684 CE \u673a\u4f1a\u548c\u62e5\u6709\u6570\u767e\u5bb6\u53c2\u5c55\u5546\u7684\u5c55\u5385\u5916\uff0c\u7f8e\u56fd\u517d\u533b\u534f\u4f1a\u8fd8\u9884\u89c8\u4e86\u5176 2012 \u5e74\u7f8e\u56fd\u5ba0\u7269\u62e5\u6709\u91cf\u548c\u4eba\u53e3\u7edf\u8ba1\u624b\u518c\u7684\u7ed3\u679c\uff0c\u5e76\u5ba3\u5e03\u63a8\u51fa\u201c\u5065\u5eb7\u5ba0\u7269\u5408\u4f5c\u4f19\u4f34\u5b9e\u8df5\u8d44\u6e90\u5de5\u5177\u7bb1\u201d\u3002<br \/>\n&nbsp;<br \/>\n************************************<br \/>\n\u516c\u53f8\u65b0\u95fb\u7a3f<br \/>\n&nbsp;<br \/>\n&gt; \u8bfa\u534e\u516c\u53f8\u83b7\u5f97 FDA \u6279\u51c6 Interceptor Spectrum \u5480\u56bc\u7247\uff08\u5421\u55b9\u916e\u548c\u7c73\u5c14\u8d1d\u809f\uff09\u3002\u9664\u4e86\u9884\u9632\u5fc3\u4e1d\u866b\u5916\uff0cInterceptor Spectrum \u8fd8\u53ef\u7528\u4e8e\u6cbb\u7597\u548c\u63a7\u5236\u6210\u5e74\u72ac\u5f13\u9996\u866b\u3001\u72ac\u5f13\u9996\u866b\u3001\u72ee\u5f13\u9996\u866b\u3001\u6b66\u666e\u6c0f\u5f13\u9996\u866b\u3001\u8c46\u72b6\u7ee6\u866b\u3001\u591a\u623f\u68d8\u7403\u7ee6\u866b\u548c\u7ec6\u7c92\u68d8\u7403\u7ee6\u866b\uff08\u7ee6\u866b\uff09\u3002\uff08\u517d\u533b\u5b9e\u8df5\u65b0\u95fb\uff09 <br \/>\n&nbsp;<br \/>\n&gt; Virbac Animal Health Inc. \u83b7\u5f97 FDA \u6279\u51c6\uff0c\u53ef\u751f\u4ea7\u7528\u4e8e\u6cbb\u7597\u7531\u6613\u611f\u5047\u4e2d\u95f4\u8461\u8404\u7403\u83cc\u83cc\u682a\u5f15\u8d77\u7684\u72ac\u7528\u5229\u6765\u8f9b\uff08\u5934\u5b62\u6c28\u82c4\uff09\u5480\u56bc\u7247\u3002\uff08\u517d\u533b\u5b9e\u8df5\u65b0\u95fb\uff09<br \/>\n&nbsp;<br \/>\n&gt; Ceva Holdings, Inc. \u5ba3\u5e03\u5c06\u5317\u7f8e\u603b\u90e8\u7684\u6240\u6709\u4e1a\u52a1\u6574\u5408\u81f3\u5176\u4f4d\u4e8e\u83b1\u5c3c\u514b\u8428\u7684\u56ed\u533a\u3002\u6b64\u4e3e\u6709\u671b\u5728\u5173\u952e\u4e1a\u52a1\u804c\u80fd\u4e4b\u95f4\u4ea7\u751f\u66f4\u597d\u7684\u534f\u540c\u6548\u5e94\uff0c\u5e76\u4f7f Ceva \u80fd\u591f\u66f4\u6709\u6548\u5730\u4e3a Ceva Biomune \u548c Ceva Animal Health \u7684\u5ba2\u6237\u63d0\u4f9b\u670d\u52a1\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09<br \/>\n&nbsp;<br \/>\n&gt; Ceva \u5ba3\u5e03\uff0cTransmune IBD \u548c Vectormune ND \u73b0\u53ef\u4e0e\u7a00\u91ca\u5242\u6df7\u5408\uff0c\u5728\u5b75\u5316\u573a\u5185\u65bd\u7528\uff08\u5728\u5b75\u5316\u65e5\u9f84\u65f6\u5375\u5185\u6216\u76ae\u4e0b\u65bd\u7528\uff09\uff0c\u4e00\u6b21\u6027\u5242\u91cf\u5373\u53ef\u63d0\u4f9b\u9488\u5bf9\u7ebd\u5361\u65af\u5c14\u75c5\u3001\u7518\u535a\u7f57\u75c5\u548c\u9a6c\u7acb\u514b\u6c0f\u75c5\u7684\u7ec8\u8eab\u4fdd\u62a4\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09 <br \/>\n&nbsp;<br \/>\n&gt; IDEXX Laboratories, Inc. \u5ba3\u5e03\u5df2\u4e0e MWI Veterinary Supply, Inc. (MWI) \u5c31\u4fee\u8ba2\u540e\u7684\u5206\u9500\u5173\u7cfb\u6761\u6b3e\u8fbe\u6210\u4e00\u81f4\uff0c\u6839\u636e\u8be5\u534f\u8bae\uff0cMWI \u5c06\u7ee7\u7eed\u5411\u7f8e\u56fd\u517d\u533b\u5ba2\u6237\u9500\u552e IDEXX \u4ea7\u54c1\uff0c\u5e76\u4e14\u5c06\u6765\u8fd8\u53ef\u4ee5\u9500\u552e\u4e0e IDEXX \u4ea7\u54c1\u7ade\u4e89\u7684\u4ea7\u54c1\u3002\u6839\u636e\u65b0\u7684\u534f\u8bae\uff0c\u9884\u8ba1\u8be5\u534f\u8bae\u5c06\u4e8e 2013 \u5e74 1 \u6708 1 \u65e5\u751f\u6548\uff0cIDEXX \u5c06\u51cf\u5c11\u5411 MWI \u9500\u552e\u4ea7\u54c1\u7684\u6807\u4ef7\u6298\u6263\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Pegasus Laboratories, Inc. \u5ba3\u5e03\u63a8\u51fa Vetadryl \u72d7\u732b\u4e13\u7528\u836f\uff0c\u8fd9\u662f\u9996\u4e2a\u517d\u7528\u8c03\u5473\u82ef\u6d77\u62c9\u660e\u7247\u5242\u3002Vetadryl \u6709 10 \u6beb\u514b\u548c 30 \u6beb\u514b\u4e24\u79cd\u8c03\u5473\u7247\u5242\uff0c\u5e76\u6709\u7075\u6d3b\u7684\u5242\u91cf\u9009\u62e9\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; DSM \u5ba3\u5e03\u5df2\u8fbe\u6210\u6700\u7ec8\u534f\u8bae\uff0c\u4ee5\u7ea6 4.65 \u4ebf\u6b27\u5143\uff08$5.75 \u4ebf\u6b27\u5143\uff09\u6536\u8d2d Tortuga Companhia Zoot\u00e9cnica Agr\u00e1ria\uff08Tortuga\uff09\u3002\u6700\u7ec8\u4ef7\u683c\u53d6\u51b3\u4e8e Tortuga 2012 \u5e74\u7684 EBITDA \u7ed3\u679c\uff0c\u6700\u9ad8\u53ef\u8fbe 4.9 \u4ebf\u6b27\u5143\u3002\u9884\u8ba1 Tortuga 2012 \u5e74\u7684\u9500\u552e\u989d\u5c06\u8fbe\u5230 3.85 \u4ebf\u6b27\u5143\uff08$4.75 \u4ebf\u6b27\u5143\uff09\u3002\uff08\u52a8\u7269\u5236\u836f\uff09 <br \/>\n&nbsp;<br \/>\n&gt; Spectrum Group \u5ba3\u5e03\uff0c\u9664\u4e86\u5411\u517d\u533b\u8bca\u6240\u3001\u6536\u5bb9\u6240\u3001\u6551\u63f4\u673a\u6784\u548c\u72ac\u820d\u51fa\u552e\u81ea\u5e26\u68c0\u6d4b\u8bd5\u5242\u76d2\u5916\uff0c\u8fd8\u5c06\u5728\u5176\u5b9e\u9a8c\u5ba4\u5185\u5904\u7406\u5355\u4e2a\u72ac\u7c7b\u75ab\u82d7\u6ef4\u5ea6\u68c0\u6d4b\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09 <br \/>\n&nbsp;<br \/>\n&gt; Lohmann Animal Health \u5ba3\u5e03\u4efb\u547d Frank Sterner \u4e3a\u8be5\u516c\u53f8\u7f8e\u56fd\u4e1a\u52a1\u7684\u9996\u5e2d\u6267\u884c\u5b98\u3002Sterner \u5148\u751f\u6b64\u524d\u66fe\u81ea 2009 \u5e74\u8d77\u62c5\u4efb\u7f8e\u56fd\u4e1a\u52a1\u603b\u88c1\u3002\uff08Animal Pharm\uff09<br \/>\n&nbsp;<br \/>\n&gt; Neogen \u516c\u53f8\u5ba3\u5e03\u63a8\u51fa\u9488\u5bf9\u674e\u65af\u7279\u83cc\u7684 ANSR \u6280\u672f\uff0c\u4ec5\u9700 20 \u5206\u949f\u7684\u53cd\u5e94\u65f6\u95f4\u5373\u53ef\u63d0\u4f9b\u7ed3\u679c\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09 <br \/>\n&nbsp;<br \/>\n&gt; Nexcyon Pharmaceuticals Inc. \u83b7\u5f97 FDA \u6279\u51c6\uff0c\u53ef\u4f7f\u7528 Recuvyra\uff08\u82ac\u592a\u5c3c\uff09\u900f\u76ae\u6eb6\u6db2\u6765\u63a7\u5236\u72ac\u5916\u79d1\u624b\u672f\u540e\u7684\u75bc\u75db\u3002\uff08\u517d\u533b\u5b9e\u8df5\u65b0\u95fb\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Nexvet Biopharma \u5ba3\u5e03\u4e0e Meiji Seika Pharma \u8fbe\u6210\u9996\u7b14\u91cd\u5927\u5546\u4e1a\u4ea4\u6613\u3002\u8be5\u4ea4\u6613\u6db5\u76d6\u4e86 Nexvet \u9996\u6b3e\u6cbb\u7597\u72ac\u7c7b\u708e\u75c7\u4ea7\u54c1\u7684\u4e9a\u6d32\u591a\u4e2a\u5730\u533a\u7684\u72ec\u5bb6\u6743\u5229\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u5370\u5ea6 \u9ed8\u6c99\u4e1c\u52a8\u7269\u4fdd\u5065\u516c\u53f8\uff08\u5728\u7f8e\u56fd\u548c\u52a0\u62ff\u5927\u79f0\u4e3a Merck Animal Health\uff09\u5ba3\u5e03\u5728\u5370\u5ea6\u63a8\u51fa Ovilis PPR\uff0c\u8fd9\u662f\u4e00\u79cd\u9488\u5bf9\u5c0f\u53cd\u520d\u52a8\u7269\u75ab\u75c5 (PPR) \u7684\u65b0\u75ab\u82d7\u3002\u8be5\u75ab\u82d7\u7531\u5370\u5ea6\u517d\u533b\u7814\u7a76\u6240 (IVRI) \u548c\u9ed8\u6c99\u4e1c\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u901a\u8fc7\u516c\u79c1\u5408\u4f5c\u5f00\u53d1\u3002Ovilis PPR \u662f\u4e00\u79cd\u57fa\u4e8e Sungri\/96 \u75ab\u82d7\u682a\u7684\u51cf\u6bd2\u6d3b\u75ab\u82d7\uff0c\u7531 IVRI \u5f00\u53d1\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09 <br \/>\n&nbsp;<br \/>\n&gt; \u82f1\u56fd Bioniche Life Sciences Inc. \u5ba3\u5e03\uff0c\u82f1\u56fd\u73af\u5883\u3001\u98df\u54c1\u548c\u519c\u6751\u4e8b\u52a1\u90e8\u517d\u533b\u836f\u54c1\u7ba1\u7406\u5c40 (VMD) \u5df2\u6279\u51c6\u8fdb\u53e3\u8be5\u516c\u53f8\u7684 O157 \u5927\u80a0\u6746\u83cc\u725b\u75ab\u82d7\uff0c\u5e76\u5728\u7279\u6b8a\u6cbb\u7597\u8bc1\u4e66 (STC) \u7684\u6761\u4ef6\u4e0b\u4f7f\u7528\u3002\u5f53\u82f1\u56fd\u6ca1\u6709\u9002\u5f53\u7684\u52a8\u7269\u75be\u75c5\u6cbb\u7597\u65b9\u6cd5\uff0c\u4f46\u53ef\u4ee5\u4ece\u5176\u4ed6\u56fd\u5bb6\u83b7\u5f97\u65f6\uff0c\u517d\u533b\u5c06\u83b7\u5f97 STC\u3002\uff08MarketWatch\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u4e2d\u56fd Genus \u7684\u732a\u9057\u4f20\u5b66\u90e8\u95e8 PIC \u5ba3\u5e03\u5df2\u4e0e\u4e2d\u56fd\u5927\u578b\u7efc\u5408\u732a\u8089\u751f\u4ea7\u4f01\u4e1a\u9655\u897f\u6768\u51cc\u78a7\u5c71\u519c\u4e1a\u96c6\u56e2 (BeSun) \u6210\u7acb\u5408\u8d44\u4f01\u4e1a\u3002Genus \u5c06\u6295\u8d44 870 \u4e07\u82f1\u9551 ($1350 \u4e07\u82f1\u9551)\uff0c\u62e5\u6709 49% \u7684\u80a1\u6743\u3002\u5b83\u8fd8\u5c06\u4e3a\u6700\u8fd1\u5efa\u6210\u7684\u6700\u5148\u8fdb\u7684\u6838\u5fc3\u519c\u573a\u63d0\u4f9b\u7ba1\u7406\uff0c\u5e76\u5c06\u63d0\u4f9b\u6765\u81ea PIC \u5168\u7403\u9ad8\u5065\u5eb7\u91d1\u5b57\u5854\u7684\u7eaf\u79cd\u732a\u79cd\u755c\u6765\u9972\u517b\u519c\u573a\u3002(Animal Pharm) <br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n\u52a8\u7269\u5065\u5eb7\u65b0\u95fb<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd \u2014 \u6c34\u6ce1\u6027\u53e3\u708e \u79d1\u7f57\u62c9\u591a\u5dde\u5ba3\u5e03\uff0c\u62c9\u65af\u963f\u5c3c\u9a6c\u65af\u53bf\u7684\u4e00\u5339\u9a6c\u88ab\u68c0\u6d4b\u51fa\u60a3\u6709\u6c34\u6ce1\u6027\u53e3\u708e (VS)\uff0c\u8fd9\u662f\u79d1\u7f57\u62c9\u591a\u5dde\u4eca\u5e74\u7b2c\u4e00\u4f8b\u6b64\u7c7b\u75be\u75c5\uff0c\u4e5f\u662f\u81ea 2006 \u5e74\u4ee5\u6765\u7b2c\u4e00\u4f8b\u786e\u8bca\u75c5\u4f8b\u3002\uff08Animal Pharm\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd \u2013 \u7acb\u6cd5 HR 1406\uff08\u201c\u516c\u5e73\u5bf9\u5f85\u5ba0\u7269\u4e3b\u4eba\u6cd5\u6848\u201d\uff09\u662f\u7f8e\u56fd\u4f17\u8bae\u9662\u7684\u4e00\u9879\u6cd5\u6848\uff0c\u8981\u6c42\u517d\u533b\u4e3a\u5176\u5f00\u7684\u4efb\u4f55\u836f\u7269\u5411\u5ba2\u6237\u63d0\u4f9b\u4e66\u9762\u5904\u65b9\uff0c\u4f46\u636e\u7f8e\u56fd\u517d\u533b\u534f\u4f1a (AVMA) \u653f\u5e9c\u5173\u7cfb\u90e8\u4e3b\u4efb\u79f0\uff0c\u8be5\u6cd5\u6848\u201c\u4eca\u5e74\u5df2\u80ce\u6b7b\u8179\u4e2d\u201d\u3002Mark Lutschaunig \u535a\u58eb\u8868\u793a\uff0c\u8be5\u6cd5\u6848\u6ca1\u6709\u53c2\u8bae\u9662\u7248\u672c\uff0c\u81ea\u63d0\u4ea4\u59d4\u5458\u4f1a\u4ee5\u6765\uff0c\u5c1a\u672a\u8ba8\u8bba\u8fc7\u3002\u4e0d\u8fc7\uff0c\u4ed6\u8ba4\u4e3a\u8be5\u6cd5\u6848\u5f88\u6709\u53ef\u80fd\u5728\u660e\u5e74\u91cd\u65b0\u63d0\u51fa\u3002\uff08DVM360\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u4e16\u754c \u2013 \u72c2\u72ac\u75c5\u9884\u9632 \u5168\u7403\u72c2\u72ac\u75c5\u63a7\u5236\u8054\u76df\u4e0e\u7f8e\u56fd\u75be\u75c5\u63a7\u5236\u548c\u9884\u9632\u4e2d\u5fc3\u5408\u4f5c\uff0c\u5ba3\u5e03\u5c06\u4e8e 2012 \u5e74 9 \u6708 20 \u65e5\u81f3 21 \u65e5\u4e3e\u529e\u7b2c\u4e09\u5c4a\u4e16\u754c\u72c2\u72ac\u75c5\u65e5\u7f51\u7edc\u7814\u8ba8\u4f1a\u3002\u7f51\u7edc\u7814\u8ba8\u4f1a\u5c06\u5b9e\u65f6\u6c47\u805a\u72c2\u72ac\u75c5\u7814\u7a76\u9886\u57df\u7684\u8457\u540d\u9886\u8896\u3001\u5065\u5eb7\u4e00\u4f53\u5021\u5bfc\u8005\u3001\u4e13\u4e1a\u4eba\u58eb\u3001\u5b66\u751f\u548c\u4e16\u754c\u72c2\u72ac\u75c5\u65e5\u6d3b\u52a8\u7b56\u5212\u8005\uff0c\u5171\u540c\u63a2\u8ba8\u72c2\u72ac\u75c5\u8fd9\u4e00\u91cd\u8981\u7684\u516c\u5171\u536b\u751f\u95ee\u9898\uff0c\u540c\u65f6\u4e3a\u5b66\u79d1\u5185\u548c\u5b66\u79d1\u95f4\u5bf9\u8bdd\u63d0\u4f9b\u4e00\u4e2a\u8bba\u575b\u3002\u53c2\u52a0\u7814\u8ba8\u4f1a\u514d\u8d39\u3002\u5982\u9700\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee <a href=\"http:\/\/www.worldrabiesday.org\/EN\/events\/wrd-webinar.html\">http:\/\/www.worldrabiesday.org\/EN\/events\/wrd-webinar.html<\/a> \uff08\u517d\u533b\u4f18\u52bf\uff09<br \/>\n&nbsp;<br \/>\n************************************<br \/>\n<strong>\u5e03\u62c9\u514b\u54a8\u8be2\u6709\u9650\u516c\u53f8<br \/>\n\u5b9e\u8df5\u7ba1\u7406<\/strong><br \/>\n&nbsp;<br \/>\nBrakke Consulting \u7684\u5b9e\u8df5\u7ba1\u7406\u987e\u95ee Jessica Goodman Lee \u5ba3\u5e03\u5728\u6700\u65b0\u4e00\u671f\u7684\u300a\u517d\u533b\u5b9e\u8df5\u65b0\u95fb\u300b\u4e0a\u53d1\u8868\u4e86\u5979\u7684\u6587\u7ae0\u201c\u4ee5\u5ba2\u6237\u4e3a\u4e2d\u5fc3\uff1a\u65b0\u7684\u5546\u4e1a\u73b0\u5b9e\u201d\u3002\u5982\u9700\u4e86\u89e3\u6709\u5173 Jessica \u670d\u52a1\u7684\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8054\u7cfb\u5979\uff1a <a href=\"mailto:jglee@brakkeconsulting.com\">jglee@brakkeconsulting.com<\/a> \u6216 919.444.3279\u3002<br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a> <br \/>\n&nbsp;<br \/>\n************************************<br \/>\nBRAKKE \u54a8\u8be2\u89c2\u70b9<br \/>\n&nbsp;<br \/>\n\u672c\u5468\u7684\u65b0\u95fb\u4e2d\u8fd8\u6709\u51e0\u4efd\u4eca\u5e74\u7684\u989d\u5916\u6536\u5165\u548c\u6536\u76ca\u62a5\u544a\u3002\u7b2c\u4e8c\u5b63\u5ea6\uff0c\u8be5\u884c\u4e1a\u7684\u6d3b\u52a8\u548c\u4e1a\u7ee9\u4ecd\u7136\u4fdd\u6301\u79ef\u6781\u6001\u52bf\u3002\u6700\u4ee4\u4eba\u9f13\u821e\u7684\u662f\uff0c\u672c\u5468\u6709\u8bb8\u591a\u4e2d\u5c0f\u578b\u4f01\u4e1a\u62a5\u544a\u4e86\u4e00\u9879\u6216\u591a\u9879\u65b0\u7684\u589e\u957f\u8ba1\u5212\u3002\u8be5\u884c\u4e1a\u7684\u53d1\u5c55\u9700\u8981\u65b0\u6280\u672f\u3001\u65b0\u4ea7\u54c1\u548c\u8d44\u91d1\u3002<\/p>\n<p>\u795d\u8d3a Ron DeHaven \u535a\u58eb\u548c\u6574\u4e2a AVMA \u56e2\u961f\u4e0a\u5468\u5728\u5723\u5730\u4e9a\u54e5\u4e3e\u884c\u7684\u5e74\u5ea6\u4f1a\u8bae\u4e0a\u53d6\u5f97\u5706\u6ee1\u6210\u529f\u3002\u4f1a\u8bae\u7684\u4e00\u5927\u4eae\u70b9\u662f\u5ba3\u5e03\u5e76\u53d1\u5e03\u4e86\u4e00\u5957\u5168\u9762\u7684\u5de5\u5177\uff0c\u4ee5\u5e2e\u52a9\u517d\u533b\u901a\u8fc7\u589e\u52a0\u5bf9\u5ba0\u7269\u7684\u9884\u9632\u6027\u62a4\u7406\u6765\u53d1\u5c55\u4ed6\u4eec\u7684\u5b9e\u8df5\u3002\u8fd9\u4e9b\u5de5\u5177\u662f\u7531\u5ba0\u7269\u9884\u9632\u4fdd\u5065\u4f19\u4f34\u5173\u7cfb (Partnership for Pet Preventive Healthcare) \u51c6\u5907\u7684\uff0c\u8be5\u7ec4\u7ec7\u662f\u7531 AVMA \u548c\u7f8e\u56fd\u52a8\u7269\u533b\u9662\u534f\u4f1a (AAHA) \u9886\u5bfc\u7684\u4e13\u4e1a\u7ec4\u7ec7\u548c\u884c\u4e1a\u8d5e\u52a9\u5546\u7ec4\u6210\u7684\u8054\u76df\u3002 <br \/>\n&nbsp;<br \/>\n\u8fd9\u4e9b\u5de5\u5177\u53ef\u514d\u8d39\u63d0\u4f9b\u7ed9\u4f34\u4fa3\u52a8\u7269\u4ece\u4e1a\u8005\uff0c\u8bf7\u8bbf\u95ee\u8be5\u4f19\u4f34\u5173\u7cfb\u7684\u7f51\u7ad9\u3002 <a href=\"http:\/\/www.partnersforhealthypets.org\">www.partnersforhealthypets.org<\/a>\u3002\u5176\u4e2d\u5305\u62ec\u5e2e\u52a9\u517d\u533b\u5b9e\u65bd AVMA \u548c AAHA \u5236\u5b9a\u7684\u9884\u9632\u4fdd\u5065\u6307\u5357\u7684\u6750\u6599\u3001\u5236\u5b9a\u66f4\u9002\u5408\u732b\u7684\u5b9e\u8df5\u7684\u4fe1\u606f\u3001\u4f20\u8fbe\u9884\u9632\u4fdd\u5065\u4ef7\u503c\u7684\u6280\u5de7\u3001\u5229\u7528\u4e92\u8054\u7f51\u548c\u793e\u4ea4\u5a92\u4f53\u7684\u8bf4\u660e\uff0c\u4ee5\u53ca\u5e2e\u52a9\u5b9e\u8df5\u542f\u52a8\u9884\u9632\u4fdd\u5065\uff08\u5065\u5eb7\uff09\u8ba1\u5212\u7684\u7efc\u5408\u6750\u6599\u3002Brakke \u987e\u95ee Jessica Lee \u548c John Volk \u53d7\u8be5\u4f19\u4f34\u5173\u7cfb\u7684\u59d4\u6258\u5f00\u53d1\u9884\u9632\u4fdd\u5065\u6750\u6599\u3002<br \/>\n&nbsp;<br \/>\n\u795d\u60a8\u5468\u672b\u6109\u5feb\u5e76\u4fdd\u6301\u51c9\u723d\uff01<br \/>\n&nbsp;<br \/>\n\u7f57\u6069\u00b7\u5e03\u62c9\u514b<br \/>\n&nbsp;<br \/>\n**********************************<br \/>\n\u672c\u7535\u5b50\u901a\u8baf\u5f52 Brakke Consulting, Inc. \u72ec\u6709\u3002<br \/>\n\u5bf9\u672c\u6587\u5185\u5bb9\u7684\u4efb\u4f55\u4f7f\u7528\u5747\u987b\u7ecf\u8fc7 Brakke Consulting, Inc. \u7684\u6279\u51c6\u5e76\u9002\u5f53\u6ce8\u660e\u6765\u6e90\u3002<br \/>\n\u6709\u5173 Brakke Consulting \u670d\u52a1\u548c\u8054\u5408\u7814\u7a76\u7684\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9 <a href=\"https:\/\/brakkeconsulting.com\/zh\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke \u54a8\u8be2\u516c\u53f8<br \/>\n12005 \u798f\u7279\u8def\uff0c530 \u5ba4<br \/>\n\u7f8e\u56fd\u5fb7\u514b\u8428\u65af\u5dde\u8fbe\u62c9\u65af 75234<\/p>","protected":false},"excerpt":{"rendered":"<p>\u6253\u5370\u7248\u672c ************************************ Brakke Consulting 2012 \u5e74 8 \u6708 10 \u65e5\u7684\u52a8\u7269\u4fdd\u5065\u65b0\u95fb\u548c\u7b14\u8bb0 \u7248\u6743\u6240\u6709 \u00a9 Brakke Consulting, Inc. \u7f16\u8f91\uff1aLynn Fondon DVM MBA ************************************ \u65b0\u95fb\u62a5\u9053\uff1a Brakke \u65b0\u95fb \u5b9e\u8df5\u7ba1\u7406 \u6536\u76ca\u65b0\u95fb Heska Nestle Spectrum Brands \u5176\u4ed6\u65b0\u95fb BeSun Bioniche Ceva \u2013 \u603b\u90e8 Ceva \u2013 \u75ab\u82d7 DSM Genus IDEXX Lohmann Meiji Seika Pharma Merck MWI Neogen Nexcyon Pharmaceuticals Nexvet Biopharma Novartis Pegasus Labs Spectrum Group Tortuga Virbac ********************************** 2012 \u52a8\u7269\u4fdd\u5065\u6295\u8d44\u8bba\u575b 2012 \u5e74 8 \u6708 28 \u65e5\uff0c\u661f\u671f\u4e8c \u582a\u8428\u65af\u57ce \u4eca\u5e74\u7684 KC \u52a8\u7269\u4fdd\u5065\u6295\u8d44\u8bba\u575b\u5c06\u6709\u6765\u81ea\u4e16\u754c\u5404\u5730\u7684 13 \u5bb6\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u53d1\u8868\u6f14\u8bb2\u3002\u6f14\u793a\u5185\u5bb9\u5305\u62ec\u8bca\u65ad\u3001\u8f93\u9001\u7cfb\u7edf\u3001\u751f\u7269\u5236\u5242\u3001\u836f\u54c1\u3001\u8bbe\u5907\u3001\u751f\u957f\u4fc3\u8fdb\u5242\u3001\u9176\u548c\u80bf\u7624\u5b66\u7b49\u3002\u8981\u6ce8\u518c\uff0c\u8bf7\u8bbf\u95ee http:\/\/www.kcanimalhealthforum.com\/index.php\/register-to-attend\/ www.kcanimalhealthforum.com *********************************** \u516c\u53f8\u6536\u76ca\u62a5\u544a &gt; Heska \u516c\u5e03\u4e86\u622a\u81f3 2012 \u5e74 6 \u6708 30 \u65e5\u7684\u7b2c\u4e8c\u5b63\u5ea6\u8d22\u52a1\u7ed3\u679c\u3002\u7efc\u5408\u6536\u5165\u4e3a $18.3 \u767e\u4e07\uff0c\u4e0e 2011 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u76f8\u6bd4\u589e\u52a0\u4e86 5%\u3002\u51c0\u6536\u5165\u4e3a $262,000\uff0c\u800c 2011 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u7684\u51c0\u6536\u5165\u4e3a $457,000\u3002\u6838\u5fc3\u4f34\u4fa3\u52a8\u7269\u4fdd\u5065\u6536\u5165\u4e3a $15.7 \u767e\u4e07\uff0c\u6bd4 2011 \u5e74\u7b2c\u4e8c\u5b63\u5ea6\u589e\u52a0\u4e86 12%\u3002\uff08MSN Money\uff09 &gt; \u96c0\u5de2\u516c\u53f8\u516c\u5e03\u4e86 2012 \u5e74\u4e0a\u534a\u5e74\u7684\u4e1a\u7ee9\u3002\u5ba0\u7269\u62a4\u7406\u6536\u5165\u589e\u52a0 8% \u81f3 CHF<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/23815\/\" class=\"view-full-post-btn\">\u67e5\u770b\u5b8c\u6574\u6587\u7ae0<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23815","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/23815\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for August 10, 2012 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke news practice management &nbsp; earnings news Heska Nestle Spectrum Brands &nbsp; other news BeSun Bioniche Ceva &#8211; headquarters Ceva &#8211; vaccines DSM Genus IDEXX Lohmann Meiji Seika Pharma Merck MWI Neogen Nexcyon Pharmaceuticals Nexvet Biopharma Novartis Pegasus Labs Spectrum Group Tortuga Virbac &nbsp; *********************************** 2012 ANIMAL HEALTH INVESTMENT FORUM Tuesday, August 28, 2012 Kansas City &nbsp; This year&rsquo;s KC Animal Health Investment Forum will feature presentations from 13 animal health companies from around the world. Presentations will include diagnostics, delivery systems, biologicals, pharmaceuticals, devices, growth promotants, enzymes and oncology among others. &nbsp; To register, go to http:\/\/www.kcanimalhealthforum.com\/index.php\/register-to-attend\/ &nbsp; www.kcanimalhealthforum.com &nbsp; *********************************** COMPANY EARNINGS RELEASES &nbsp; &gt; Heska reported financial results for its second quarter ended June 30, 2012. Consolidated revenue was $18.3 million, an increase of 5% compared to the second quarter of 2011. Net income was $262,000 compared to net income of $457,000 in the second quarter of 2011. Core Companion Animal Health revenue was $15.7 million, a 12% increase over the second quarter of 2011. (MSN Money) &nbsp; &gt; Nestl\u00e9 S.A. reported results for the first half of 2012. Pet Care revenues increased 8% to CHFView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/23815\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2012-08-10T17:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:07:36+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23815\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23815\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for August 10, 2012\",\"datePublished\":\"2012-08-10T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:07:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23815\/\"},\"wordCount\":1722,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23815\/\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/23815\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2012-08-10T17:51:17+00:00\",\"dateModified\":\"2018-04-14T07:07:36+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23815\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/zh\/23815\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23815\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for August 10, 2012\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/23815\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for August 10, 2012 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke news practice management &nbsp; earnings news Heska Nestle Spectrum Brands &nbsp; other news BeSun Bioniche Ceva &#8211; headquarters Ceva &#8211; vaccines DSM Genus IDEXX Lohmann Meiji Seika Pharma Merck MWI Neogen Nexcyon Pharmaceuticals Nexvet Biopharma Novartis Pegasus Labs Spectrum Group Tortuga Virbac &nbsp; *********************************** 2012 ANIMAL HEALTH INVESTMENT FORUM Tuesday, August 28, 2012 Kansas City &nbsp; This year&rsquo;s KC Animal Health Investment Forum will feature presentations from 13 animal health companies from around the world. Presentations will include diagnostics, delivery systems, biologicals, pharmaceuticals, devices, growth promotants, enzymes and oncology among others. &nbsp; To register, go to http:\/\/www.kcanimalhealthforum.com\/index.php\/register-to-attend\/ &nbsp; www.kcanimalhealthforum.com &nbsp; *********************************** COMPANY EARNINGS RELEASES &nbsp; &gt; Heska reported financial results for its second quarter ended June 30, 2012. Consolidated revenue was $18.3 million, an increase of 5% compared to the second quarter of 2011. Net income was $262,000 compared to net income of $457,000 in the second quarter of 2011. Core Companion Animal Health revenue was $15.7 million, a 12% increase over the second quarter of 2011. (MSN Money) &nbsp; &gt; Nestl\u00e9 S.A. reported results for the first half of 2012. Pet Care revenues increased 8% to CHFView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/zh\/23815\/","og_site_name":"Brakke Consulting Website","article_published_time":"2012-08-10T17:51:17+00:00","article_modified_time":"2018-04-14T07:07:36+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Brakke Consulting","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"9 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/zh\/23815\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/23815\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for August 10, 2012","datePublished":"2012-08-10T17:51:17+00:00","dateModified":"2018-04-14T07:07:36+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/23815\/"},"wordCount":1722,"articleSection":["Newsletter"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/zh\/23815\/","url":"https:\/\/brakkeconsulting.com\/zh\/23815\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2012-08-10T17:51:17+00:00","dateModified":"2018-04-14T07:07:36+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/zh\/23815\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/zh\/23815\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/zh\/23815\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for August 10, 2012"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"\u5e03\u62c9\u514b\u54a8\u8be2\u516c\u53f8","url":"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23815","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=23815"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23815\/revisions"}],"predecessor-version":[{"id":25293,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23815\/revisions\/25293"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=23815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=23815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=23815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}